History and experience: The direction of Alzheimer's disease

Menopause

Volumn 19, Issue 7, 2012, Pages 724-734

  Reichman, William E ^a   Rose, Nathan S ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ROTMAN RESEARCH INSTITUTE   (Canada)

Author keywords

Alzheimer disease; Brain fitness; Dementia; History; Prevention

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; CYANOCOBALAMIN; DONEPEZIL; ESTROGEN; FOLIC ACID; GALANTAMINE; GESTAGEN; MEMANTINE; RIVASTIGMINE; TACRINE; TAU PROTEIN; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DAMAGE; CEREBROSPINAL FLUID EXAMINATION; CHROMOSOME 21; COGNITION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ENVIRONMENTAL EXPOSURE; EXERCISE; EXERCISE TEST; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HEALTH STATUS; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; LIFESTYLE MODIFICATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL SUPPORT; POSITRON EMISSION TOMOGRAPHY; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; RISK FACTOR; SEX DIFFERENCE; SOCIAL BEHAVIOR;

ALZHEIMER DISEASE; CONSUMER ADVOCACY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; RISK FACTORS;

EID: 84863515973     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31825a28f2     Document Type: Article

References (76)

1. Wimo A, Prince M. World Alzheimer Report 2010: The Global Economic Impact of Dementia. London, UK: Alzheimer's Disease International 2010. Available at: http://www.alz.co.uk/research/world-report. Accessed January 27, 2012
2. Alzheimer A. About a peculiar disease of the cerebral cortex. Alzheimer Dis Assoc Disord 1987;1:3-8
3. Kraepelin E. Psyciatrie: in Lehrbuch fur Studierende und Arzte, 8th ed. Leipzig, Germany: Barth, 1910
4. Berchtold NC, Cotman CW. Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol Aging 1998;19:173-189 (Pubitemid 128714320)
5. Newton RD. The identity of Alzheimer's disease and senile dementia and their relationship to senility. J Ment Sci 1948;94:225-249
6. Neumann MA, Cohn R. Incidence of Alzheimer's disease in large mental hospital; relation to senile psychosis and psychosis with cerebral arteriosclerosis. AMA Arch Neurol Psychiatry 1953;69:615-636
7. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811
8. Katzman R. Editorial: the prevalence and malignancy of Alzheimer disease. A major killer. Arch Neurol 1976;33:217-218
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944 (Pubitemid 14076461)
10. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981;10:122-126 (Pubitemid 11053099)
11. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984;122:1131-1135 (Pubitemid 14027629)
12. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein T (T) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913-4917
13. Kosik KS, Joachim CL, Selkoe DJ. Microtubule-associated protein T (T) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 1986;83:4044-4048 (Pubitemid 16062419)
14. St George-Hyslop PH, Tanzi RE, Polinsky RJ, et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987;235:885-890 (Pubitemid 17019126)
15. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on AgingYAlzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7: 270-279
16. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297: 353-356 (Pubitemid 34790756)
17. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 13;261:921-923
18. Raschetti R, Albanese E, Vanacore N, Maggini M. Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials. PLoS Med 2007;4:e338
19. Cummings J. Alzheimer's disease: clinical trials and the amyloid hypothesis. Ann Acad Med Singapore 2011;40:304-306
20. Golde TE, Schneider LS, Koo EH. Anti-aA therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron 2011;69:203-213
21. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on AgingYAlzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292
22. Shaw LM. PENN biomarker core of the Alzheimer's Disease Neuroimaging Initiative. Neurosignals 2008;16:19-23 (Pubitemid 350308317)
23. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-128
24. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004;55: 306-319 (Pubitemid 38269583)
25. De Meyer G, Shapiro F, Vanderstichele H, et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol 2010;67:949-956
26. Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on AgingYAlzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:257-262
27. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on AgingYAlzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-269
28. Hampel H, Prvulovic D, Teipel S, et al. The future of Alzheimer's disease: the next 10 years. Prog Neurobiol 2011;95:718-728
29. de la Torre JC. Basics of Alzheimer's disease prevention. J Alzheimers Dis 2010;20:687-688
30. Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ. Predictive value of APOE-D4 allele for progression from MCI to AD-type dementia: a meta-analysis. J Neurol Neurosurg Psychiatry 2011;82:1149-1156
31. Xiong C, Roe CM, Buckles V, et al. Role of family history for Alzheimer biomarker abnormalities in the adult children study. Arch Neurol 2011;68:1313-1319
32. Janicki SC, Schupf N. Hormonal influences on cognition and risk for Alzheimer's disease. Curr Neurol Neurosci Rep 2010;10:359-366
33. Barnes DE, Cauley JA, Lui LY, et al. Women who maintain optimal cognitive function into old age. J Am Geriatr Soc 2007;55:259-264 (Pubitemid 46184403)
34. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002;288:2123-2129 (Pubitemid 35265379)
35. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2663-2672 (Pubitemid 37430137)
36. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662 (Pubitemid 37430136)
37. Coker LH, Hogan PE, Bryan NR, et al. Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. Neurology 2009;72:125-134
38. Resnick SM, Espeland MA, An Y, et al. Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy. J Clin Endocrinol Metab 2009;94:4152-4161
39. Stern Y, Albert S, Tang MX, Tsai WY. Rate of memory decline in AD is related to education and occupation: cognitive reserve? Neurology 1999;53:1942-1947
40. Reichman WE, Fiocco AJ, Rose NS. Exercising the brain to avoid cognitive decline: examining the evidence. Future Med Aging Health 2010;6: 565-584
41. Bialystok E, Craik FI, Klein R, Viswanathan M. Bilingualism, aging, and cognitive control: evidence from the Simon task. Psychol Aging 2004;19: 290-303 (Pubitemid 38720874)
42. Craik FI, Bialystok E, Freedman M. Delaying the onset of Alzheimer disease: bilingualism as a form of cognitive reserve. Neurology 2010;75: 1726-1729
43. Schweizer TA, Ware J, Fischer CE, Craik FI, Bialystok E. Bilingualism as a contributor to cognitive reserve: evidence from brain atrophy in Alzheimer's disease [e-pub]. Cortex 2011
44. Luk G, Bialystok E, Craik FI, Grady CL. Lifelong bilingualism maintains white matter integrity in older adults. J Neurosci 2011;31:16808-16813
45. Middleton LE, Yaffe K. Targets for the prevention of dementia. J Alzheimers Dis 2010;20:915-924
46. Kolb B, Gibb R. Principles of neuroplasticity and behavior. In: Stuss D, Winocur G, Robertson I, eds. Cognitive Neurorehabilitation: Evidence and Application, 2nd ed. New York, NY: Cambridge University Press, 2008:6-21
47. Valenzuela M, Sachdev P. Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. Am J Geriatr Psychiatry 2009;17:179-187
48. Siedlecki KL, Manly JJ, Brickman AM, Schupf N, Tang MX, Stern Y. Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? Neuropsychology 2010;24:402-411
49. Jak AJ. The impact of physical and mental activity on cognitive aging. Curr Top Behav Neurosci 2012;10:273-291
50. Papp KV, Walsh SJ, Snyder PJ. Immediate and delayed effects of cognitive interventions in healthy elderly: a review of current literature and future directions. Alzheimers Dement 2009;5:50-60
51. Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev 2003;4:CD003260
52. Sitzer DI, Twamley EW, Jeste DV. Cognitive training in Alzheimer's disease: a meta-analysis of the literature. Acta Psychiatr Scand 2006;114: 75-90 (Pubitemid 44034266)
53. Seidler A, Bernhardt T, Nienhaus A, Frolich L. Association between the psychosocial network and dementiaVa case-control study. J Psychiatr Res 2003;37:89-98 (Pubitemid 36808471)
54. Carlson MC, Erickson KI, Kramer AF, et al. Evidence for neurocognitive plasticity in at-risk older adults: the experience corps program. J Gerontol A Biol Sci Med Sci 2009;64:1275-1282
55. Carlson MC, Saczynski JS, Rebok GW, et al. Exploring the effects of an Beveryday[ activity program on executive function and memory in older adults: experience corps. Gerontologist 2008;48:793-801
56. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-2242 (Pubitemid 39473161)
57. Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007;166:367-378 (Pubitemid 47216800)
58. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetesVsystematic overview of prospective observational studies. Diabetologia 2005;48:2460-2469 (Pubitemid 41738208)
59. Feart C, Samieri C, Rondeau V, et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 2009;302:638-648
60. Scarmeas N, Stern Y, Tang M-X, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006;59: 912-921 (Pubitemid 43830923)
61. Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N. Food combination and Alzheimer disease risk: a protective diet. Arch Neurol 2010;67:699-706
62. Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M. Midlife healthy-diet index and late-life dementia and Alzheimer's disease. Dement Geriatr Cogn Dis Extra 2011;1:103-112
63. Plassman BL, Williams JW Jr, Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 2010;153:182-193
64. Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol 2011;68:1239-1244
65. Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol 2011;68:1385-1392
66. Smith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One 2010;5:e12244
67. Bayer-Carter JL, Green PS, Montine TJ, et al. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol 2011;68:743-752
68. Ravaglia G, Forti P, Lucicesare A, et al. Physical activity and dementia risk in the elderly: findings from a prospective Italian study. Neurology 2008;70:1786-1794 (Pubitemid 351653964)
69. Lautenschlager NT, Cox KL, Flicker L, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008;300:1027-1037
70. Erickson KI, Colcombe SJ, Elavsky S, et al. Interactive effects of fitness and hormone treatment on brain health in postmenopausal women. Neurobiol Aging 2007;28:179-185 (Pubitemid 44894626)
71. Klusmann V, Evers A, Schwarzer R, et al. Complex mental and physical activity in older women and cognitive performance: a 6-month randomized controlled trial. J Gerontol A Biol Sci Med Sci 2010;65:680-688
72. Baker LD, Frank LL, Foster-Schubert K, et al. Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease. J Alzheimers Dis 2010;22:569-579
73. Baker LD, Bayer-Carter JL, Skinner J, et al. High-intensity physical activity modulates diet effects on cerebrospinal amyloid-A levels in normal aging and mild cognitive impairment. J Alzheimers Dis 2012;28: 137-146
74. Scarmeas N, Luchsinger JA, Schupf N, et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 2009;302:627-637
75. Rolland Y, Pillard F, Klapouszczak A, et al. Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J Am Geriatr Soc 2007;55:158-165 (Pubitemid 46184389)
76. Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil 2004;85:1694-1704 (Pubitemid 39349417)